AIP
RLAY icon

Ameritas Investment Partners’s Relay Therapeutics RLAY Stock Holding History

Ameritas Investment Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
14,669
+3,489
+31% +$50.6K 0.01% 1203
2026
Q1 		$111K Hold
11,180
– – ﹤0.01% 1632
2025
Q4 		$94.6K Sell
11,180
-1,550
-12% -$11.1K ﹤0.01% 1742
2025
Q3 		$66.5K Hold
12,730
– – ﹤0.01% 1935
2025
Q2 		$44K Hold
12,730
– – ﹤0.01% 2266
2025
Q1 		$33.4K Hold
12,730
– – ﹤0.01% 2326
2024
Q4 		$52.4K Buy
12,730
+3,760
+42% +$20.5K ﹤0.01% 2149
2024
Q3 		$63.5K Hold
8,970
– – ﹤0.01% 2056
2024
Q2 		$58.5K Hold
8,970
– – ﹤0.01% 2057
2024
Q1 		$74.5K Hold
8,970
– – ﹤0.01% 1915
2023
Q4 		$98.8K Hold
8,970
– – ﹤0.01% 1741
2023
Q3 		$75.4K Buy
8,970
+2,159
+32% +$23.2K ﹤0.01% 1847
2023
Q2 		$85.5K Hold
6,811
– – ﹤0.01% 1701
2023
Q1 		$112K Hold
6,811
– – ﹤0.01% 1460
2022
Q4 		$142K Buy
6,811
+1,013
+17% +$19.4K 0.01% 1357
2022
Q3 		$129K Hold
5,798
– – 0.01% 1317
2022
Q2 		$97K Buy
5,798
+390
+7% +$8.36K ﹤0.01% 1534
2022
Q1 		$162K Hold
5,408
– – 0.01% 1317
2021
Q4 		$166K Buy
5,408
+818
+18% +$25.9K 0.01% 1346
2021
Q3 		$145K Hold
4,590
– – 0.01% 1454
2021
Q2 		$168K Buy
4,590
+860
+23% +$28.3K 0.01% 1379
2021
Q1 		$129K Buy
3,730
+987
+36% +$42.8K ﹤0.01% 1503
2020
Q4 		$114K Hold
2,743
– – 0.01% 1506
2020
Q3 		$117K Buy
+2,743
New +$105K 0.01% 1340

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Ameritas Investment Partners's RLAY Position: Q2 2026 in Review

Ameritas Investment Partners increased its Relay Therapeutics (RLAY) stake by 31% in Q2 2026, buying an estimated $50.6K and bringing the position to 14,669 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #1203.

Ameritas Investment Partners first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Ameritas Investment Partners held 14,669 shares of Relay Therapeutics worth $274K as of Q2 2026.
  • Ameritas Investment Partners bought 3,489 Relay Therapeutics shares in Q2 2026, an estimated $50.6K.
  • Relay Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1203 holding.
  • Ameritas Investment Partners first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.